Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cloud Automation is Speeding Up Innovation in Pharma and Life Sciences


News provided by

Morpheus Data

Oct 10, 2022, 08:30 ET

Share this article

Share toX

Share this article

Share toX


The Morpheus hybrid cloud management platform speeds up innovation while decreasing risk, in highly regulated industries, such as life sciences and pharma.

GREENWOOD VILLAGE, Colo., Oct. 10, 2022 /PRNewswire-PRWeb/ -- In recent years, the life sciences and pharma industries have experienced an increase in regulatory oversight while also facing pressure to respond to global healthcare crises. This tension between regulation and innovation will only increase as security and data privacy concerns limit the ability of many industries to take advantage of public cloud services.

Looking forward, as technology expands, these industries will continue to see a steady escalation in regulations. "By optimizing data sharing and advancing collaboration and innovation, cloud computing can facilitate world-changing discoveries."¹ Herein lies a unique difficulty for those operating within life sciences and pharma industries — organizations must innovate at the fastest pace possible to compete while still adhering to critical regulatory requirements. As the reliance on technology increases, the pace of R&D in pharma and life sciences is becoming bottlenecked by internal IT processes that are historically unable to compete with the speed of service delivery provided by public clouds.

Researchers and scientists need on-demand access to application services, but compliance concerns mean they are not able to simply go to the public cloud like those in other industries

Post this

"In highly regulated sectors, there has been a lot of frustration on the part of teams that feel handcuffed by legacy approaches to IT," Brad Parks, Chief Product and Marketing Officer at Morpheus Data. "Researchers and scientists need on-demand access to application services, but compliance concerns mean they are not able to simply go to the public cloud like those in other industries."

This is where Morpheus Data provides innovative hybrid cloud management technology that makes it possible for researchers and teams to move faster while still meeting strict regulatory guidelines and process controls. Through a unified orchestration and automation platform, teams get instant on-demand access to the applications they need to advance their research agenda without having to wait on manual IT processes. Individual users can request organizationally approved application services from a simple self-service portal or API, which means they can constantly analyze data sets, iterate, and test again without delay. At the same time, IT and security teams are able to set strict policies around where applications are deployed and how data is accessed. By retaining critical control of organization-wide governance, IT can protect the organization from risk.

With the Morpheus hybrid cloud management platform, organizations can get the speed and efficiency of the public cloud within the safety and security of their on-premises datacenter. The platform integrates with the datacenter tools and hypervisors that organizations already have, reducing the number of manual tasks that must be performed each time an application service is provisioned. This helps those operating in highly regulated environments access the data sets and applications they need to perform testing in minutes rather than waiting days, weeks, or months for IT to provide assistance.

One Morpheus Data client, AstraZeneca, cites that a service delivery process that previously took 80 hours per server end-to-end can now be accomplished in 27 minutes, start to finish. AstraZeneca also found they saved over six-million dollars in IT overhead by automating their hybrid-cloud estate with Morpheus.

In the future, pharma and life sciences organizations that are highly automated will be poised to be able to innovate the fastest. These teams will be able to process patents, receive approvals, and move through the FDA at speed. Automating and orchestrating private cloud environments will allow these teams to operate efficiently while still adhering to strict security and regulation requirements.

To learn more about how Morpheus can help speed up innovation while reducing risk, download the whitepaper Market Insight Report.

About Morpheus Data:
Morpheus Data is the leader in hybrid cloud application orchestration, helping hundreds of organizations in life science, pharmaceutical, financial services, and other industries unleash productivity and address IT operations skills gaps through their unified software platform. The Morpheus platform enables self-service provisioning of VMs, Containers, Clusters, and Application Stacks into any private or public cloud while staying within policy guardrails. For more information and to request a personalized platform demo, visit http://www.morpheusdata.com/demo.

Reference:
1. Team, E. (2020, December 17). Why do biotech and pharma need so much computing power in the cloud? Atlantic.Net. Retrieved October 6, 2022, from https://www.atlantic.net/life-sciences-pharma-biotech/biotech-pharma-need-much-computing-power-cloud/

Media Contact

Karla Jo Helms, JOTO PR™, 727-777-4619, [email protected]

Twitter

SOURCE Morpheus Data

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.